Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: A double-blind, placebo-controlled, comparative study
Open Access
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (6) , 661-666
- https://doi.org/10.1023/a:1008256115221
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Potential for combination therapy with the new antiserotonergic agentsEuropean Journal Of Cancer, 1993
- A Comparative Study of the Use of Navoban (ICS 205-930), a 5-HT3 Antagonist, versus a Standard Antiemetic Regimen of Dexamethasone and Metoclopramide in the Treatment of Cisplatin-Containing ChemotherapyClinical Drug Investigation, 1993
- The control of acute cisplatin-induced emesis – a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasoneBritish Journal of Cancer, 1993
- Comparison of Ondansetron with Customary Treatment in the Prophylaxis of Nausea and Emesis Induced by Non-Cisplatin Containing ChemotherapyActa Oncologica, 1993
- A comparison of granisetron as a single agent with conventional combination antiemetic therapies in the treatment of cytostatic-induced emesisEuropean Journal Of Cancer, 1992
- TropisetronDrugs, 1992
- Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?BMJ, 1991
- Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapyThe Lancet, 1991
- Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and VomitingAnnals of Internal Medicine, 1990
- A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.Journal of Clinical Oncology, 1990